Shinmura K, Hasegawa H, Ishida H, Shimizu K, Ebihara Y, Koyama T, Iwanaga S, Honma S, Tani M, Handa S
Department of Geriatrics, School of Medicine, Keio University.
Kokyu To Junkan. 1993 Nov;41(11):1107-11.
In 1970, a 19 year-old man was diagnosed as having coarctation of the aorta (CoA). But the patient and his family rejected further examination for CoA and high blood pressure was treated after that time. When the patient was 37 years old, he was admitted to our hospital because of congestive heart failure. During the 2nd admission for determining the operability of CoA in December, 1988, non-sustained ventricular tachycardia was detected. Immediately, intravenous administration of lidocaine or/and mexiletine were started. However, cardiac arrest occurred. After his recovery, lethal ventricular arrhythmias were still observed frequently despite administration of class Ia or Ib antiarrhythmic drugs. Oral amiodarone administration (600 mg) with procainamide (1000 mg) was started on 1st of May, 1989. Axillo-femoral bypass graft was performed during the 2nd admission because curable operation was abandoned because of severely impaired cardiac function. Subsequently, the patient was admitted 5 times due to exacerbated congestive heart failure. However, lethal arrhythmias were able to be controlled by the combination of low dose amiodarone (100-200 mg) with procainamide until he died of congestive heart failure on 9th of May, 1992. We reported a rare adult case with CoA and severe heart failure. Lethal arrhythmias in this case were well controlled by the combined administration of low dose amiodarone with procainamide regardless of severely impaired cardiac function.
1970年,一名19岁男性被诊断为主动脉缩窄(CoA)。但患者及其家属拒绝了进一步的CoA检查,此后仅对高血压进行了治疗。患者37岁时,因充血性心力衰竭入住我院。1988年12月,患者第二次入院以确定CoA的手术可行性时,检测到非持续性室性心动过速。随即开始静脉注射利多卡因或/和美西律。然而,患者发生了心脏骤停。复苏后,尽管使用了Ia类或Ib类抗心律失常药物,仍频繁观察到致命性室性心律失常。1989年5月1日开始口服胺碘酮(600 mg)和普鲁卡因胺(1000 mg)。由于心脏功能严重受损,放弃了根治性手术,在第二次住院期间进行了腋股旁路移植术。随后,患者因充血性心力衰竭加重又入院5次。然而,在1992年5月9日患者死于充血性心力衰竭之前,低剂量胺碘酮(100 - 200 mg)与普鲁卡因胺联合使用能够控制致命性心律失常。我们报告了一例罕见的患有CoA和严重心力衰竭的成年病例。尽管心脏功能严重受损,但该病例中的致命性心律失常通过低剂量胺碘酮与普鲁卡因胺联合给药得到了良好控制。